SG Americas Securities
IMVT icon

SG Americas Securities’s Immunovant IMVT Stock Holding History

SG Americas Securities’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$566K Sell
22,801
-22,847
-50% -$592K ﹤0.01% 2108
2025
Q4 		$1.16M Sell
45,648
-16,950
-27% -$378K ﹤0.01% 1895
2025
Q3 		$1.01M Buy
62,598
+54,570
+680% +$883K ﹤0.01% 1449
2025
Q2 		$128K Buy
+8,028
New +$121K ﹤0.01% 2525
2024
Q4 		– Sell
-15,944
Closed -$455K – 3352
2024
Q3 		$455K Sell
15,944
-14,758
-48% -$435K ﹤0.01% 1769
2024
Q2 		$811K Buy
30,702
+26,546
+639% +$755K ﹤0.01% 1420
2024
Q1 		$134K Sell
4,156
-25,781
-86% -$941K ﹤0.01% 2312
2023
Q4 		$1.26M Sell
29,937
-66,766
-69% -$2.46M 0.01% 901
2023
Q3 		$3.71M Buy
96,703
+50,795
+111% +$1.15M 0.04% 406
2023
Q2 		$871K Buy
45,908
+13,208
+40% +$246K 0.01% 1124
2023
Q1 		$507K Buy
32,700
+11,673
+56% +$203K 0.01% 1710
2022
Q4 		$373K Buy
21,027
+4,323
+26% +$54.4K ﹤0.01% 1762
2022
Q3 		$93K Sell
16,704
-5,918
-26% -$28.9K ﹤0.01% 2873
2022
Q2 		$88K Buy
+22,622
New +$97.7K ﹤0.01% 3162
2022
Q1 		– Sell
-15,032
Closed -$128K – 3201
2021
Q4 		$128K Sell
15,032
-12,717
-46% -$105K ﹤0.01% 2922
2021
Q3 		$241K Buy
+27,749
New +$250K ﹤0.01% 3102
2021
Q2 		– Sell
-90,479
Closed -$1.45M – 3034
2021
Q1 		$1.45M Buy
90,479
+86,126
+1,979% +$2.27M 0.01% 1270
2020
Q4 		$201K Sell
4,353
-2,689
-38% -$124K ﹤0.01% 2624
2020
Q3 		$248K Sell
7,042
-3,379
-32% -$102K ﹤0.01% 2031
2020
Q2 		$254K Buy
+10,421
New +$223K ﹤0.01% 2652

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

SG Americas Securities's IMVT Position: Q1 2026 in Review

SG Americas Securities reduced its Immunovant (IMVT) stake by 50% in Q1 2026, selling an estimated $592K and leaving 22,801 shares worth $566K. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

SG Americas Securities first reported a position in IMVT in Q2 2020 and has held it in 20 quarters since. The position peaked at $3.71M in Q3 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • SG Americas Securities held 22,801 shares of Immunovant worth $566K as of Q1 2026.
  • SG Americas Securities sold 22,847 Immunovant shares in Q1 2026, an estimated $592K.
  • Immunovant made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2108 holding.
  • SG Americas Securities first reported a position in Immunovant in Q2 2020 and has held it in 20 quarters since.
  • SG Americas Securities's Immunovant position peaked at $3.71M in Q3 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.